The 11th International Workshop on Hepatitis C: Resistance and New Compounds took place on 26 May 2016 as a half-day program of the 14th European Meeting on HIV & Hepatitis (Rome, Italy, 25 - 27 May 2016).
The exciting progress in the development of Hepatitis C antivirals provides hope for new treatment strategies to clear this virus from infected individuals. Our understanding of Hepatitis C virus replication, its pathogenesis and resistance is increasing as these new antivirals progress through clinical development to the market, however many questions remain. The objective of this program is to provide an international forum where all questions and recent progress in the development and study of Hepatitis C antivirals can be discussed among researchers from academia and industry with key clinical investigators.
The next edition of this meeting is preliminarily scheduled to take place during the 15th edition of the European Meeting on HIV & Heptitis (7 - 9 June 2017, Rome, Italy).
The Organizing Committee